# European Partnership for Personalised Medicine \- EP PerMed

> EP PerMed is a coordination platform for personalised medicine, bringing together national and regional ministries, funding organisations, agencies and authorities from Europe and beyond to promote research, innovation and the implementation of personalised medicine\.

Generated by Yoast SEO v28.0, this is an llms.txt file, meant for consumption by LLMs.

## Seiten
- [Data privacy](https://www.eppermed.eu/data-privacy/)
- [Best Practices and Advances and Learnings in Personalised Medicine](https://www.eppermed.eu/publications-resources/ep-permed-publications/best-practices/)
- [Reports](https://www.eppermed.eu/publications-resources/ep-permed-publications/reports/)
- [JTC2025](https://www.eppermed.eu/members-area/ep-permed-jtcs/jtc2025/)
- [JTC2024](https://www.eppermed.eu/members-area/ep-permed-jtcs/jtc2024/)

## News
- [Round Table Report Highlights Pathways to Implement Personalised Medicine in Nordic Countries](https://www.eppermed.eu/news-events/news/round-table-report-highlights-pathways-to-implement-personalised-medicine-in-nordic-countries/): EP PerMed has published the summary report of its third round table, which examined challenges, successful approaches and industry perspectives on the implementation of personalised medicine in the Nordic countries\.

The round table took place on 18 May 2026 in Copenhagen, Denmark, bringing together representatives from companies, healthcare innovation organisations, public funding bodies and national personalised medicine infrastructures\.
- [Chips JU Opens Call to Reinforce Europe’s Strength in Health](https://www.eppermed.eu/news-events/news/chips-ju-opens-call-to-reinforce-europes-strength-in-health/): The Chips Joint Undertaking \(Chips JU\) has opened a new call supporting the development and industrial deployment of advanced electronic components and systems for healthcare\. The one\-stage Innovation Action is open for applications until 16 September 2026\.
- [New Resources on Personalised Medicine Strategies, Policy and Regulations](https://www.eppermed.eu/news-events/news/new-resources-on-personalised-medicine-strategies-policy-and-regulations/): EP PerMed has published three new resources that bring together national, regional, and transnational policy documents and legal instruments relevant to the development and implementation of personalised medicine\.
- [New EP PerMed FAQ Explains Key Concepts in Personalised Medicine](https://www.eppermed.eu/news-events/news/new-ep-permed-faq-explains-key-concepts-in-personalised-medicine/): EP PerMed has published a new Frequently Asked Questions page offering a clear introduction to personalised medicine, its practical applications, and the conditions needed for its responsible implementation across Europe\.
- [EP PerMed Publishes Report on Returning Biobank Data to Participants](https://www.eppermed.eu/news-events/news/ep-permed-publishes-report-on-returning-biobank-data-to-participants/): EP PerMed has published a report on its session “Returning Biobank Data to Participants: Closing the Loop”, organised together with BBMRI\-ERIC during Europe Biobank Week 2026 in Prague\.

## Beneficiaries
- [Beneficiary 436](https://www.eppermed.eu/beneficiaries/beneficiary-436/)
- [Beneficiary 426](https://www.eppermed.eu/beneficiaries/beneficiary-426/)
- [Beneficiary 388](https://www.eppermed.eu/beneficiaries/beneficiary-388/)
- [SPOCK \- Fundación para la Investigación de Málaga en Biomedicina y Salud \(FIMABIS\)](https://www.eppermed.eu/beneficiaries/spock-fundacion-para-la-investigacion-de-malaga-en-biomedicina-y-salud-fimabis/)
- [ECPM \- University Hospital Erlangen](https://www.eppermed.eu/beneficiaries/ecpm-university-hospital-erlangen/)

## Projects
- [PerMIDRIAR](https://www.eppermed.eu/funding-projects/projects-results/project-database/permidriar/): In our well\-established longitudinal cohorts of all participating countries \(Canada, the Netherlands, Germany, Sweden, Italy\) we have collected detailed data \(information of patient history\) and blood samples\. From this data, we will identify the subgroup of high\-risk children and perform an analysis on immune cells of the blood and arthritic joints using novel analytical methods \(Fig\. 1\.\) together with available patient data \(Fig 2\.\) to identify mechanisms and origins of the disease\.
- [HiRisk\-HiGain](https://www.eppermed.eu/funding-projects/projects-results/project-database/hirisk-higain/): The HiRisk\-HiGain trial will address whether complementation of standard immuno\-chemotherapy \(red line\) by a consolidation treatment with Tigecycline and Venetoclax increases the frequency of disease eradication – i\.e\. cure – in MYC/BCL2\-associated diffuse large\-B cell lymphoma \(DLBCL\)\. Patients will be enrolled based on positivity for MYC and BCL2 \(with either IHC or FISH\) and the achievement of primary remission with remaining risk factors \(slow responders or detectable minimal residual disease\), and will include a subset of «double\-hit» cases with dual translocations\. Repeated liquid biopsy \(blood sampling\) and monitoring of minimal residual disease shall allow to anticipate eventual relapse and to unravel the genetic correlates \(or biomarkers\) of treatment response\. Complementary experiments in pre\-clinical models \(mice\) shall validate those biomarkers and highlight the mechanisms connecting them to treatment response\.

- [PRISM](https://www.eppermed.eu/funding-projects/projects-results/project-database/prism/): The PRISM networking event aims to bring together a transnational and interdisciplinary community to address key translational challenges in Personalised Medicine, with a specific focus on the role of subject specific Digital Twins \(DTs\) in advancing personalised radiotherapy\. The event will serve as a platform to consolidate lessons learned, harmonise methodological approaches, and define future directions for translational research on DTs in oncology\.
- [VOICE PM](https://www.eppermed.eu/funding-projects/projects-results/project-database/voice-pm/): While personalised medicine offers groundbreaking diagnostic and therapeutic potential, its successful integration into healthcare requires the early, continuous inclusion of patient perspectives\. The Voice PM project aims to organise a networking event which addresses the vital need for meaningful patient involvement in translational research for personalised medicine\. 
- [GENCareSim](https://www.eppermed.eu/funding-projects/projects-results/project-database/gencaresim/): The GENCareSim module is a 4\-week, simulation\-based educational programme designed for healthcare professionals involved in survivorship care for patients with hereditary breast and ovarian cancer \(HBOC\) and Lynch syndrome\. It integrates personalised medicine into real\-world clinical decision\-making through interactive scenarios, focusing on molecular diagnostics, risk communication, and interdisciplinary coordination\.

## Publications
- [Schizophrenia polygenic risk is associated with child mental health problems through early childhood adversity: evidence for a gene–environment correlation](https://www.eppermed.eu/publications/schizophrenia-polygenic-risk-is-associated-with-child-mental-health-problems-through-early-childhood-adversity-evidence-for-a-gene-environment-correlation/)
- [Genome\-wide association study of more than 40,000 bipolar disorder cases provides new insights into the underlying biology](https://www.eppermed.eu/publications/genome-wide-association-study-of-more-than-40000-bipolar-disorder-cases-provides-new-insights-into-the-underlying-biology/)
- [Association of Gestational Age at Birth With Brain Morphometry](https://www.eppermed.eu/publications/association-of-gestational-age-at-birth-with-brain-morphometry/)
- [Genetic risk for Alzheimer disease in children: Evidence from early\-life IQ and brain white\-matter microstructure](https://www.eppermed.eu/publications/genetic-risk-for-alzheimer-disease-in-children-evidence-from-early-life-iq-and-brain-white-matter-microstructure/)
- [Engram\-specific transcriptome profiling of contextual memory consolidation](https://www.eppermed.eu/publications/engram-specific-transcriptome-profiling-of-contextual-memory-consolidation/)

## Events
- [25th International Gene Forum in Tartu](https://www.eppermed.eu/news-events/events/25th-international-gene-forum-in-tartu/)
- [EP PerMed 3rd Round Table: Challenges and Best Practices in the Implementation of Personalised Medicine Approaches in Nordic Countries \- Industry View](https://www.eppermed.eu/news-events/events/ep-permed-round-table-3rd-edition-challenges-and-best-practices-in-the-implementation-of-personalised-medicine-approaches-in-nordic-countries-industry-view/)
- [Implementation School on Personalised Medicine \- A Sex\- and Gender\-Sensitive Approach](https://www.eppermed.eu/news-events/events/implementation-school-on-personalised-medicine-a-sex-and-gender-sensitive-approach/): Join our Implementation School on Personalised Medicine, focused on integrating sex and gender perspectives into clinical practice, research, and health systems\. Despite growing evidence, sex\- and gender\-related differences remain under\-represented in healthcare decision\-making \- yet they play a critical role in disease risk, diagnosis, treatment response, and patient experience\.
- [ICPerMed Webinar on Genomics Infrastructures and AI\-Enabled Omics](https://www.eppermed.eu/news-events/events/icpermed-webinar-on-genomics-infrastructures-and-ai-enabled-omics/)
- [PRISM Networking Event: Digital Twins for Personalised Radiotherapy through Integrated Simulation and Modelling](https://www.eppermed.eu/news-events/events/prism-networking-event-digital-twins-for-personalised-radiotherapy-through-integrated-simulation-and-modelling/)

## Download Kategorien
- [JTC2022](https://www.eppermed.eu/?dlm_download_category=jtc2022)
- [JTC2018](https://www.eppermed.eu/?dlm_download_category=jtc2018)
- [JTC2019](https://www.eppermed.eu/?dlm_download_category=jtc2019)
- [JTC2020](https://www.eppermed.eu/?dlm_download_category=jtc2020)
- [JTC2021](https://www.eppermed.eu/?dlm_download_category=jtc2021)

## Optional
- [Sitemap index](https://www.eppermed.eu/sitemap_index.xml)